GlassScriptPhysician profile
Steven P Lawrence
NPI 1487641106
$9,325.64
in general payments reported to CMS, 2019-2025
35 companies · none reported in 2025
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,301 · 2020: $648 · 2021: $1,551 · 2022: $2,098 · 2023: $1,811 · 2024: $1,918.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,533 · Education: $133 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $62.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,532.78 |
| Education | $133.41 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $62.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,428.33 | 2019-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $928.42 | 2019-2024 | Entyvio, Gattex |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $900.51 | 2019-2024 | Xifaxan, Trulance |
| Janssen Biotech, INC. | $857.84 | 2019-2024 | Stelara, Simponi Aria, Simponi |
| Gilead Sciences, INC. | $735.30 | 2019-2024 | |
| Celgene Corporation | $530.68 | 2021-2024 | Zeposia |
| Regeneron Healthcare Solutions, INC. | $379.09 | 2022-2024 | Dupixent |
| Intercept Pharmaceuticals, INC. | $355.05 | 2019-2024 | Ocaliva |
| Pfizer INC. | $277.17 | 2019-2024 | |
| Genzyme Corporation | $234.33 | 2022-2024 | |
| Allergan, INC. | $228.12 | 2020 | |
| Qol Medical, LLC | $222.37 | 2019-2024 | Sucraid |
| Lilly USA, LLC | $174.21 | 2023-2024 | Omvoh |
| Celltrion USA INC. | $137.33 | 2024 | Vegzelma, Zymfentra |
| Ucb, INC. | $85.88 | 2019-2020 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ardelyx, INC. | $83.00 | 2023-2024 | Ibsrela |
| Alexion Pharmaceuticals, INC. | $77.88 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $64.36 | 2021-2024 | Rebyota |
| Aimmune Therapeutics, INC. | $62.50 | 2023 | |
| Nestle Healthcare Nutrition INC. | $60.31 | 2021-2023 | |
| Ironwood Pharmaceuticals, INC | $56.97 | 2019-2022 | |
| Phathom Pharmaceuticals, INC. | $53.31 | 2024 | Voquezna |
| Daiichi Sankyo INC. | $53.17 | 2022-2024 | Injectafer |
| Ipsen Biopharmaceuticals, INC | $48.30 | 2024 | Iqirvo |
| Shionogi INC | $45.89 | 2019 | |
| Redhill Biopharma INC. | $44.67 | 2021-2022 | |
| Ethicon US, LLC | $36.41 | 2019 | |
| Medtronic, INC. | $34.44 | 2021 | |
| Echosens North America, INC. | $26.23 | 2024 | Fibroscan |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.00 | 2023 | Cyltezo |
| Shire North American Group INC | $23.73 | 2019 | |
| Cook Medical LLC | $16.93 | 2019 | |
| Braintree Laboratories, INC. | $13.81 | 2022 | |
| Romark Laboratories, Lc | $13.73 | 2019 | |
| Alfasigma USA, INC. | $11.37 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Lawrence listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.